Physician profile
Sarah Samreen
NPI 1427233303
$133,247.87
in general payments reported to CMS, 2019-2025
10 companies · $26K in 2025
The $26K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $14K · 2021: $4,747 · 2022: $30K · 2023: $36K · 2024: $23K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $55K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Travel and Lodging: $4,901 · Food and Beverage: $2,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $55,300.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $22,000.00 |
| Travel and Lodging | $4,900.76 |
| Food and Beverage | $2,346.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $131,830.80 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Jazz Pharmaceuticals INC. | $373.00 | 2019-2025 | |
| Medtronic, INC. | $272.61 | 2022-2024 | Signia |
| Harmony Biosciences LLC | $249.98 | 2022-2024 | |
| Glaxosmithkline, LLC. | $241.33 | 2022-2023 | Arexvy |
| Avadel Specialty Pharmaceuticals, LLC | $112.92 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $97.10 | 2021 | |
| Davol INC. | $32.94 | 2019 | |
| Heron Therapeutics, INC. | $24.13 | 2023 | Zynrelef |
| C. R. Bard, INC. & Subsidiaries | $13.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Samreen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.